Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Academy/Journal Finder/Nature Reviews Drug Discovery

Drug discovery

Nature Reviews Drug Discovery

Springer Nature (Nature Portfolio)

Drug discovery and development, from medicinal chemistry and clinical trials to toxicology, patent law, pharmacoeconomics and regulation

ISSN 1474-1776 (print)ISSN 1474-1784 (online)
Verified 2026-11Field-level — see each tab
CiteScoreNot yet verified
Impact FactorNot yet verified
QuartileQ1 2025 · SCImago
Article Fee (APC)Not yet verified
First DecisionNot yet verified
Acceptance RateNot disclosed by publisher

Overview

Nature Reviews Drug Discovery is published by Springer Nature (Nature Portfolio). Drug discovery and development, from medicinal chemistry and clinical trials to toxicology, patent law, pharmacoeconomics and regulation

Key information

PublisherSpringer Nature (Nature Portfolio)
ISSN (Print)1474-1776
ISSN (Online)1474-1784
Publishing modelNot yet verified
Journal websitewww.nature.com/nrd/
CountryUnited Kingdom
FrequencyMonthly
Subject categoryDrug discovery and development
EditorPeter Kirkpatrick (Chief Editor)
EstablishedNot yet verified
SubmissionsNot yet verified

Like other Nature titles, the journal has no external editorial board: decisions are made by full-time professional editors who are PhD-level scientists. Reviews are commissioned from leaders in the field and peer reviewed. Editor named on the journal’s subscription page; confirm on the editors page.

Aims & scope

A monthly journal for everyone working in drug discovery and development. Its coverage includes:

  • Medicinal chemistry
  • Clinical trials
  • Toxicology
  • Patent law
  • Pharmacoeconomics
  • Regulatory issues

Each issue carries commissioned reviews and perspectives, plus news, highlights of key primary papers and updates on approvals, patent law and industry trends. Nature Reviews journals publish non-primary content only, so original research is not considered.

From the journal’s nature.com pages (journal information and subscription pages), SCImago 2025 and PubMed records for the sample articles, November 2026.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.